Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

Blood. 2008 Nov 1;112(9):3696-703. doi: 10.1182/blood-2008-05-155408. Epub 2008 Aug 12.

Abstract

Microenvironment molecular cues direct T helper (Th) cell differentiation; however, Th17 fate determination is still imprecisely understood in humans. To assess the role of prostaglandin E(2) (PGE(2)) in Th expansion, we activated peripheral blood mononuclear cells by CD3 cross-linking. In the presence of exogenous PGE(2), peripheral blood mononuclear cells produced higher interleukin-17 (IL-17), C-C chemokine ligand 20 (CCL20)/macrophage inflammatory protein 3alpha (MIP-3alpha), CXC chemokine ligand 8 (CXCL8)/IL-8, and lower interferon-gamma and IL-22 levels than in control cultures. Exogenous PGE(2) and IL-23 synergized in inducing IL-17, whereas indomethacin and IL-23 blockade drastically reduced IL-17 but not interferon-gamma production. Furthermore, IL-1 but not tumor necrosis factor was absolutely required for IL-17 production. PGE(2) doubled the frequency of CD4+ T cells producing IL-17 and within the CD4+ subset enhanced C-C chemokine receptor 6 (CCR6) and CCR4 while decreasing CXC chemokine receptor 3 (CXCR3) expression. Furthermore, in CD4+ T-cell lines, the production of IL-17 segregated with the CCR6+ subset. In the presence of CCR6+ compared with CXCR3+ Th cells, monocytes/macrophages produced much higher levels of matrix metalloproteinase-1, -3, and -9 but similar levels of CXCL10 and IL-1beta. These results identify PGE(2) and IL-23 as participating in the expansion of CD4+ T cells endowed with high IL-17 production capacity, which in turn favors monocyte production of mediators important for host defense and tissue destruction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Coculture Techniques
  • Dinoprostone / administration & dosage*
  • Dinoprostone / metabolism
  • Drug Synergism
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / metabolism
  • Interleukin-17 / biosynthesis*
  • Interleukin-23 / administration & dosage*
  • Interleukin-23 / metabolism
  • Macrophages / immunology
  • Macrophages / metabolism
  • Matrix Metalloproteinases / biosynthesis
  • Monocytes / immunology
  • Monocytes / metabolism
  • Receptors, CCR4 / metabolism
  • Receptors, CCR6 / metabolism
  • Recombinant Proteins / administration & dosage
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / drug effects*
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocytes, Helper-Inducer / cytology
  • T-Lymphocytes, Helper-Inducer / drug effects*
  • T-Lymphocytes, Helper-Inducer / immunology*
  • T-Lymphocytes, Helper-Inducer / metabolism

Substances

  • CCR4 protein, human
  • CCR6 protein, human
  • Interleukin-1
  • Interleukin-17
  • Interleukin-23
  • Receptors, CCR4
  • Receptors, CCR6
  • Recombinant Proteins
  • Interferon-gamma
  • Matrix Metalloproteinases
  • Dinoprostone